
Meet our team
Our leadership team has an extensive background in medical, orthopedics, neurosurgery, and spine surgery robotics.
Founders

Bertin Nahum
Bertin Nahum

Successful entrepreneur in Surgical Robotics :
Prior to Quantum Surgical, Bertin NAHUM founded Medtech SA (Rosa® Surgical Robot – neuro and spine surgery) in 2002, took the company public (IPO) in 2013 and sold it to Zimmer Biomet (NYSE: ZBH) in 2016.
Previously, he pioneered the development of robot-assisted solutions in various surgical specialties at Computer Motion Inc. (Zeus, AESOP – laparoscopic surgery) and Integrated Surgical Systems Inc. (ROBODOC – orthopedic surgery).
Bertin Nahum graduated from the National Institute of Applied Sciences (FR) and holds a Master of Science in Robotics and a Doctorate of Technology Honoris Causa from Coventry University (UK).
He was awarded the Legion of Honor in the rank of Chevalier in 2013.

Fernand Badano
Fernand Badano

Fernand has 25+ years of experience as Chief Operating Officer and on the Board of Directors of multiple innovative medical technology companies.
He served as General Manager and Board Director of Medtech SA.
Fernand Badano holds a PhD degree from National Institute of Applied Sciences (FR).

Lucien Blondel
Lucien Blondel

Sophie Roca
Leadership

Christophe Sibillin
Christophe Sibillin

Laetitia Messner
Laetitia Messner

Hervé Cointement

Jean-Michel Bredon
Jean-Michel Bredon

Jean-Michel BREDON has 10+ years of experience in the healthcare sector and 20+ years of experience in Information Systems and Organization Management.
Previous experience include the position of hospital director in charge of information systems and organization, as well as being the Referring Director of the Medical-Technical Department in several hospitals.

Stéphane Amalfi
Stéphane Amalfi

Yann Le Meur
Yann Le Meur

Andrew Zeringue

Thomas Klug

Board Members
Bertin Nahum
Bertin Nahum

Successful entrepreneur in Surgical Robotics :
Prior to Quantum Surgical, Bertin NAHUM founded Medtech SA (Rosa® Surgical Robot – neuro and spine surgery) in 2002, took the company public (IPO) in 2013 and sold it to Zimmer Biomet (NYSE: ZBH) in 2016.
Previously, he pioneered the development of robot-assisted solutions in various surgical specialties at Computer Motion Inc. (Zeus, AESOP – laparoscopic surgery) and Integrated Surgical Systems Inc. (ROBODOC – orthopedic surgery).
Bertin Nahum graduated from the National Institute of Applied Sciences (FR) and holds a Master of Science in Robotics and a Doctorate of Technology Honoris Causa from Coventry University (UK).
He was awarded the Legion of Honor in the rank of Chevalier in 2013.
Fernand Badano
Fernand Badano

Fernand has 25+ years of experience as Chief Operating Officer and on the Board of Directors of multiple innovative medical technology companies.
He served as General Manager and Board Director of Medtech SA.
Fernand Badano holds a PhD degree from National Institute of Applied Sciences (FR).
Lucien Blondel
Lucien Blondel
Frank Yu
Frank Yu

Frank is Founder, CEO and CIO of Ally Bridge Group (ABG), a leading global life sciences investment specialist having generated billions of dollars of value from its life science investments in China, the US and Europe, integrated between the private and public markets. ABG is dual-headquartered in New York and Hong Kong, also with teams in California and Israel. Frank and his team excel in leading high-impact life science transactions with a strong focus on the world’s most cutting-edge life science innovations at later stages, primarily in the US, and in deal-making between emerging technologies and industry giants, and across geographies.
Prior to founding and running Ally Bridge, Frank was a Managing Director at Goldman Sachs, then at Och-Ziff Capital where he was Head of China Investments. Previously, Frank had worked at Credit Suisse in Hong Kong and London, Moody’s and Thomson Financial in New York.
With a passion for art and world cultures and commitment to philanthropy, Frank serves on the Board of Trustees to the Solomon R. Guggenheim Foundation.
Kevin Reilly
Kevin Reilly
Kevin Reilly joined Ally Bridge Group in 2021 and is a Managing Director, Special Investments, for the private equity strategy focused on transactions across healthcare subsectors. Before joining Ally Bridge Group, Kevin was a Principal at CRG, a healthcare investment management firm providing growth capital to companies through the form of long-term debt and equity. Kevin began his career in the Healthcare Investment Banking Group at Stifel Nicolaus. Kevin holds a BS in Finance and Information Systems from the University of Maryland.
Robert Thompson
Robert Thompson

Robert Thompson (Bob) is an accomplished marketing and business development leader and brings Quantum Surgical his experience in product development and commercialization in the medtech industry. He previously served as President-Ultrasound Siemens Healthineers, senior leadership positions at GE Healthcare and medical device start-ups.
Joseph de Vivo
Joseph de Vivo
Joseph de Vivo brings over 30 years of experience in medical device, robotics and digital health industries. He was most recently Executive Chairman of Caption Health, President of Hospitals and Health Systems for Teladoc Health and CEO of InTouch Health. He previously served as CEO of Angiodynamics and President of Smith & Nephew Orthopedics. Mr DeVivo currently serves as the Treasurer of the American Telemedicine Association and on the Board of Governors for St Jude Children’s Research Hospital.
Scientific Advisory Board
Prof. Steven D. Colquhoun (USA)
Prof. Steven D. Colquhoun (USA)
Prof. Steven D. Colquhoun is Liver Transplant Surgeon, specialized in robotic surgery. He completed fellowship training in both transplantation and surgical oncology at UCLA. He is board certified in both surgery and critical care, and has been more recently appointed Floyd C. Harrell, Jr MD Distinguished Chair, Surgery, Professor at Medical College of Georgia.
Dr. Colquhoun is involved in clinical and translational research aimed at improving both the diagnosis and treatment of hepatocellular carcinoma as well as other primary and metastatic liver tumors such as colorectal cancer and neuroendocrine tumors.
Prof. Laurent Milot (France)
Prof. Laurent Milot (France)
Prof. Laurent Milot is Deputy Chief Vascular & Interventional Radiology at the Hospices Civils de Lyon (France).
After finishing medical school at Paris V, Pr Milot got his MD and MSc at the university of Lyon as a specialist in radiology. After a fellowship at the University of Toronto, he was subsequently hired as assistant professor in the medical imaging department and staff radiologist at Sunnybrook Health Science Center. He became associate professor, associate vice-chair of research and associate member at the IMS. After 11 years in Toronto, he came back to Lyon as deputy chief of the department of medical imaging at the Hôpital Edouard Herriot. His subspecialty is in diagnostic and interventional hepatobiliary and GI body radiology. After getting his PhD and HDR, he has been appointed as Full Professor of Diagnostic and Interventional Radiology in September 2021 at the University Claude Bernard Lyon 1 and Hospices Civils de Lyon. Since then, he has been building an innovative clinical and research program linking innovations in diagnostic (radiomics, AI) and interventional (robotics, multimodal treatment) radiology.
Dr. Govindarajan Narayanan (USA)
Prof. Thierry de Baere (FR)
Prof. Thierry de Baere (FR)
Prof. Thierry de Baere is Head of the Therapeutic Imaging Department (interventional radiology) at Gustave Roussy Cancer Center.
Prof. de Baère devotes his work to minimally invasive therapies in the treatment of kidney, lung, and liver cancers. He focuses mainly on intra-arterial therapies for primary and secondary liver tumors and percutaneous liver tumor ablation with radiofrequency and cryoablation.
Prof. Luigi Solbiati (IT)
Prof. Luigi Solbiati (IT)
Luigi Solbiati worked from 1980 to 2015 at the General Hospital of Busto Arsizio (Varese), rising from Assistant Radiologist to Chairman of the Department of Oncology and Head of the Division of Interventional Oncologic Radiology.
He pioneered ultrasound-guided aspiration biopsies (1979), ethanol injection (1983), radiofrequency ablation with cool-tip electrodes (1995) and microwaves (2009) of solid tumors and fusion imaging for the guidance of interventional procedures (2003). In parallel, he has been serving as an adjunct Professor of “Techniques and Methods of Diagnostic Imaging” from 1988 to 2014 at the School of Radiology of the University of Milan.
He gave more than 480 scientific presentations at Meetings, Congresses and Courses in 23 countries. He has been Guest Lecturer at the Universities of San Diego, Zurich, Beijing, Hong Kong, New Delhi, Cairo, Vienna, Yale and at the Mayo Clinic (Rochester). Chairman of the 1st World Conference on Interventional Oncology (Cernobbio, Italy) in 2006. Chairman of the 1st Interventional Oncology Sans Frontieres Congress (IOSFC) (Cernobbio, Italy) in 2013.

Quantum Surgical is recruiting
At Quantum Surgical, we are recruiting the brightest minds and most creative innovators that thrive in a start-up environment.